Brian Dardzinski is one of the highly regarded advisory board members of the Demarest Clinic. He is the founder of Regenerative Medicine Co. Ltd., operating in South-East Asia for 15 years distributing MedTech and stem cell technologies through an established distributor and clinic network. Over the last 25 years, he has been dynamic in senior corporate roles, leading successful organizations. Having worked for several fortune 500 companies such as Tyco International, Thermo Fisher Scientific, he gathered an extensive management experience spanning healthcare, budget management, business intelligence, strategic planning, and due diligence.

Mr Dardzinski was the global vice president of an Australian adult stem cell company for five years.

In 2010 he negotiated exclusive countrywide licensing distribution agreements to expand to six continents and 54 countries. He also served as a CEO of Regenerative Medicine International Inc.

and oversaw a formal clinical trial at Chulalongkorn University with the Queen Sirikit Center for breast cancer in Bangkok. He established Stem Cell Therapy Programs for Cardiovascular (Chronic Ischemia and Cardiomyopathy) and Peripheral Artery Disease indications while working for an Israeli based Stem Cell firm. In his 17 years of an active career in South-East Asia, he accomplished recognition and successfully executed projects focusing on most advanced healthcare technologies and cell therapies. After an outstanding performance at the Bumrungrad International Hospital as the Senior Director of Research and Development, Mr Dardzinski was promoted to head their Integrative Wellness Center. Here he was responsible for facilitating growth by initiating new product strategies, digitalizing clinical practices, and developing an application to assist clinicians in Anti-ageing, Detoxification, Wellness etc. and rebrand clinic’s image.